China Reform Health reports semi-annual loss amid strategic shifts

China Reform Health Management And Services Group announced a net loss attributable to shareholders of CNY -99,090,685.40 for the first half of 2025, a 35.78% increase from the previous year. Operating revenue decreased by 30.47% to CNY 95,530,059.44. This decline is attributed to a restructuring of the health services segment and decreased revenue in the digital medical segment.

The company also reported significant changes in its board and supervisory board composition, with new directors and supervisors elected, and an updated senior management team appointed on May 6, 2025. Additionally, the company adjusted its organizational structure, dissolving the PBG data research and development department and establishing an AI center to consolidate AI initiatives.

Strategic shifts include reallocating CNY 184.6635 m in unused raised capital to future market opportunities, as property acquisition plans for several projects were deferred due to real estate market volatility. The company also announced a share repurchase plan of 2,077,060 shares, amounting to CNY 10,509,923.60, due to unfulfilled performance targets and employee departures.